IHS Chemical Week

Markets :: Specialty Chemicals :: Personal Care

DSM Acquires U.S. Biotech R&D Firm, Microbia

1:37 AM MDT | September 22, 2010 | Natasha Alperowicz

DSM has announced the acquisition of Microbia Inc. (Lexington, MA) from Ironwood Pharmaceuticals. Terms of the deal were not disclosed. Microbia is an industrial biotechnology R&D firm with only limited sales. It has developed a "highly effective" technology platform for the production of high-quality natural carotenoids, including beta-carotene and canthaxanthin, as well as nutritional products and other specialty materials and chemicals from renewable resources. The acquisition will allow DSM to incorporate Microbia's proprietary platform and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa